SH7-12886-83012
2 vaccinations
2 coded responses
9 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 301 / GA
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, NauseaAdult check-in
- 2020-12-20
- 2020-12-22
-
2020-12-27
Health check-in — day 7, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tirednessAdult check-in
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-15
Health check-in — day 7, dose 2Feeling: Good · Site: Pain · Joint pains · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-15
Report sent to call center — day 7, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-02-05
Survey response — day 28, dose 2MedDRA: Nausea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: NauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-15
-
2021-07-09
Survey response — 6 months, dose 2MedDRA: Neuropathy peripheral — Feeling: GoodFree text: Neuropathy to extremitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 3 — day 28, dose 2
Symptoms: Nausea
Release 9 — 6 months, dose 2
Symptoms: Neuropathy to extremities
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Neuropathy peripheral | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release